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Traditionally. models of the determinants of myocardial 
is&.&a have been based on the relations between myocar- 
dial oxygen demand and supply. Situations in which myo- 
cardial oxygen demand is increased resull in ischemia when 
not accompanied by a concomitant increase in myoeardial 
oxygen delivery. This concept implies the existence of a 
fixed ischemtc threshold dependent on demand alone in the 
presence of a fixed supply secondary to coronary anery 
stew& (1). However. other factors are also operative 
becattse the ischemic threshold has been shown to be 
variable (2-8). Recent evtience so&was that work loads and 
myoeardial oxygen uptake at the&et of ischemia can be 
altered during diiering exercise conditions. For example. 
Garber et al. (6) found that ischemin. as measured by 
electrocardiographic (ECG) changes and symptoms, occurs 
at lower work loads when a slowly progressing exercise 
protocol is used. These studies imply that ischemia may 
&cur at lower thresholds during normal daily activities than 
would be predicted by standard Bruce protocol exercise 
testing, an obsetwdioo contimxd in nutncmu~ ambulatory 
ECG studies G-5.5). Hence. factors other than mvocardial 
demand may alter.the &he& threshold. One possibility is 
the role of diEerential vasodilation produced by vasoaetive 
substances such as adeoosine (g-13). 
Adenosine is a powerful coronary vascdilator endoge- 
nously released in response to myocardial ixhemia to pm- 
mote increased myocardial blood Row (12.13). However, the 
vasodilating etfects of adenosine in the presence of existing 
coronary disease result in a preferential increase in coronary 
blood Row to areas of myoeardium that are not supplied by 
stenotic coronary artery vessels and therefore may exagger- 
ate ischemia. The inhibition of adenosine may prevent or 
delay this coronary steal pheoomenon at a given work load 
and thereby raise the irchemic threshold (lo). 
Agents such as methylxanthittes that inhibit awtosine 
may be elfectivc in reducing or delaying ischemic events 
without ltering the detemtinants of myocxdial oxy@i 
demand. Such compounds may produce alternote avenues of 
therapy to the traditional classes of drugs (that is. beta- 
adrenergic blocking agents, calcium antagonists and ni- 
trates). In confirmation of this concept, the methylxanthine 
theophylline has been shown to delay the onset of exercise- 
induced ischemia and to prolong exercise duration (14-17). 
Unfortunately, little is known regarding the mechanisms of 
the effects of theophylline, particularly in relation to the 
action of adenosine. IO addition, data from other studier 
have suggested that theophylline may exert deleterious 
effects on the myoeardium that may limit its clinical utility 
(18-20). 
The present study was undertaken to evaluate the effects 
of theophylline on exercise-induced myocardial ischemia 
and to fiiher explore the mechanisms of these actions. The 
influence of theophylline on the onset of ischemia and peak 
exercise was evaluated by determining clinical variables, 
hemodynamic effects, oxygen uptake and comparative 
thalliumlftl imaging (21,22). 
M&IOdS 
Patllt seIe&on. Patients referred for exercise thallium- 
201 studies were screened for inclusion in this study. Pa- 
tients who were in a clinically stable condition and who 
met the following criteria were eligible for study entry: 
I) exercise-induced horizontal or downsloping ST segment 
depression ~0.1 mV, 2) reversible thallium-201 defect by 
both qualitative and computer-assisted quantitative criteria, 
and 3) post-test likelihood of significant eoronaty artery 
disease 295% (23). 
Patients were excluded from the study if any of the 
following were present: 1) ECG evidence of left ventricular 
hypertrophy, left bundle branch block or other baseline ST 
segment abnormalities rendering the exercise ECG uninter- 
pretable; 2) known allergies to theophylline or current ther- 
apy with theophylline or other hronchodilators; 3) asthma or 
reactive airways disease: 4) diioxin therapy. 
Study design. The study was a randomized, double-blind, 
placebo-controlled, crossover trial of intravenous theophyl- 
line using a replicated 2 x 2 Latin square design. After 
obtaining informed consent, subjects completed two bse- 
line exercise tests and two exercise tests with thallium-201 
imaging, which were preceded by an intravenous infusion of 
either theopbylline or placebo. 
Calcium channel antagonists and beta-blocking agents 
were withdrawn for 48 h before testing. Nitrates, other than 
sublitwual. were withheld oo the dav oflestine. The exercise 
studies were administered 7 lo IO &ys apart: 
Procedures and anal@s. Exercise resting. The exercise 
tests were administered at the same time in the morning for 
a given patient after a minimum of a 4-h fast. The exercise 
tests were symptom limited and used the standard Bruce 
protocol (24). Twelve-lead ECGs were recorded during each 
minute of exercise and until return to baseline afterexercisc. 
Oxygen uptake was measured during each minute of exer- 
cise. Tests were terminated because of ST segment depres. 
sion 20.4 mV, complex ventricular arrhythmias, induced 
hypotension, progresiive limiting angina or fatigue (24). 
Medicorion ~rorocol. Afler prewation for ECG moni- 
toring and deikrmination of baseline blood pressure and 
heart rate, each patient was randomized to a 30.min infusion 
of theophylline (5 m&g ideal body weight as the ethylene- 
diamine salt, aminophylline) or an equivalent volume of 
saline placebo in 108 ml of saline solution. Ideal body weight 
was calculated as follows: for men, 50 kg + 2.3 kg for every 
inch (2.54 cm) over 5 feet (1.52 m); for women, 45.5 kg t 
2.3 kg for every inch over 5 feet (25). During the infusion, 
three ECG leads and patient symptoms were monitored, and 
the blood pressure and IZlead ECG were recorded every 
IO min. Exrcire :esting immediately followed the drug 
infusion. 
Oxygen uptake methods. Oxygen uptake was measured 
during each exercise test by open circuit indirect calorimetry 
with ao Ametek S-3A oxygen analyzer, a Beckman LB-2 
carbon dioxide (COJ analyzer, and a Hewlett-Packard 
heated digital pneumotach (model 47303A). Measurements 
of oxygen uptake were made using a Douglas bag method 
with collection of 30-s mixed expired air samples (26). 
Before each test, the volume measu~ments were confirmed 
using a j-Ii& syringe, and the oxygen end CO, analyzers 
were calibrated by using a gas with known concentrations of 
oxygen and carbon dioxide (about 15% 0,: 4% COJ. verified 
by the micro-Scholattder technique (27). 
Thallium-201 imaging. Patients received an injection of 
2.5 to 3.0 mCi thallium-201 I min before the end ofexereise 
after the placebo and theophyuitte infusions. Planar intogin 
WBS begun within 10 min using three standard views: ante- 
rior, 3P left anterior oblique and 70” left anterior oblique. 
Patients returned approximately 4 h later far delayed imag- 
ing. 
Data anaIy& and Intm~mWbn. The ECCs were aua- 
lyzed without knowledge of patient identity or trealment by 
consensus of two experietteed cardiilogis~s. For each sub- 
ject, the lead ShOWiog the greatest ST segment depression 
was determined on the first test read and was utilized on all 
subsequent tests. Data extracted from the ECGs included 
the lime of onset of 0.1 mV horizontal or downsloping ST 
segment depression, ST segment depression at peak exer- 
cise, total exercise duralion and time to axe: of angina 
pectolis. 
The thallium-B L images were analyzed visually and with 
computer-assisted qttantitation. Images were interpreted by 
consensus by three experienced observers without knwl- 
edge of the drug omtocol or oaticnt identitv. Thallium-201 
h&es from no& patients&d patients &pa,::ipating in 
the study were included to reduce bias. Ihe let7 ventricular 
images were divided into 15 segments: each segment was 
scored on a scale of 0 to 3 (0 = uorral, 1 = slight photon 
emission reduction, 2 = mudemte photon emission rcduc- 
tion. 3 = backgtwnd or absent activity). Scoring of I5 
segments resulted in a range of 0 to 4Slpatient (28). 
Thallium-201 images were also analyzed quantitatively 
with a computer-assisted method (291. An ~pemor- 
determined ellipse was filled around the Left vekcular 
region of all three initial imaw. The imases were realigned 
to-fit within the ellipse, and-weighted background subirac- 
lion was perfomxd. Thallium-201 activity profile scores 
were derived and normalized to the hottest Y-point smoothed 
pixel within the ellipse of the initial images. The left ventric- 
ular activity was subdivided into five segments of equal 
length around the perineter. Mean normalized seamental 
th&tm-201 a&it; was then determined (30). Appiication 
of this procedure to all three stress planar images resulted in 
a possible range of 0% to 3tX% per patient. 
TheapI ~Uine assay. Whole blood samples were collected 
al peak exercise in a lube without additive and immediately 
swt at I ,zoO X g for I5 min. The wematant was enmcted 
a;ld frozen immediately. Samples w&e stored at - 10°C until 
assayed (<I month). Theophylline was assayed by using 
the theophylline tw*part rate lest with a Kodak Ektachem 
clinical analyzer (model 400). Duplicate serw. samples 
(10 4) were analyzed with the methodoloav described bv 
Kodak (publication MFQ-46). 
_. 
Data analysis slrategy. Statistical analyses were per- 
fortoed by using a repeated meawes approach to the 
analyses of variance (31). When indicated, post-hoc testing 
was performed with the Tttkey HSD test (32). Data are 
reported as the mean value ? SD. The significance level was 
set at p < 0.05 
Figam 1. Elects of intravenws theophylline on 
the onset of angina pecloris in eight patients. 
siikanl dikxence betueen tbeapbyltine (3 
and both placebofP)and baseline Et): *p < 0.0s: 
*‘p < 0.01. V02 = oxygen consumption (ml/kg 
per rain). Ltlwd pressure is expressci in mm Hg. 
heart rate in beats&n and heart rate-blood 
pressure pmduci in arbitrary units. 
Twelve mea met the study criteria and completed the 
entire orotocol. All patients had a historv of stable aneiaa 
peclo&. and seven dad evidence of prior ~yocwdial in&c- 
tion. All patients were receiving anti-ischemic medications, 
and I I were taking more than one drug. 
Effects of thewhvftbe w exercisz iscbem& The mean . . 
theophyllinc level at peak exercise in these patients was 
8.0 + 2.0 mgJliter. The effects of theophyllin; on exercise 
variables are illustrated in Table 1. Theoohvlline sic& . . _ 
cantly delayed the time of onset of bath ECG changes and 
angina pectoris and significantly increased the total exercise 
duration. Oxygen uptake was significantly greater at peak 
exercise after theophylline administration. There were no 
significant ditTerenccs between the baseline and placebo 
values for any of the exercise variables measured. 
Eight patients experienced angina pectoris doting the 
exercise prolccol. The time to the onset of angina was 
significantly delayed atIer theophylline infusion, whereas 
there were no sigoiticant dierences between the aoginal 
responses at baseline nod with placebo (Table I). The onset 
of angina occurred at a significantly higher heart tattte. 
systolic bled pressure and heart rate-systolic blood pres- 
sure product aller Iheophylline infusion (Fig. I). The oxygen 
uptake at the onset of angina was also significantly greater 
after theophylline infusion. 
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A similar evaluation was made for the onset of ECG 
chanaes (12 oatients. Fia. 2). As with the onset of andna, the 
heari&., hystolic bl&d pressure, rate-pressure-product 
and oxygen uptake at the onset of ECG changes were 
significantly greater with theophylline infusion than with 
either placebo or at baseline. 
Effects of thenphyUhte on tfudRum-201 imaging. The ef- 
fects of theophylline on the location and t&me of &hernia 
were evaluated using thallium-201 imaging at peak exercise 
(Table 2). After both olacebo and theoohvlline infusions. all 
patients.had either completely reversible in = 7) or partially 
reversible (II = 5) defects. Visual assessment performed in 
blinded fashion revealed no differences in either the severity 
or the extent of the defects based on the number of segments 
involved. Computerized quantitative analysis confirmed no 
significant diierences in the percentage of abnormal myo- 
cardial images between theophylline- and placebo-treated 
patients. 
The side effects of the theophylline infusion were moni- 
tored. During and after the theophylline infusions, there was 
no increase in the number of ventricular ectopic beats, 
baseline heart rate n: LLui pressure (Table I) or symptoms 
such as nausea, headache and vomiting. 
Discussion 
This double-blind, placebocontrolled crossover trial 
was performed to evaluate the effects of theophylline on 
exercise-induced myocardial ischemia. Theophyllinc not 
only delayed the onset of exercise-induced ischemia but also 
proloqed exercise duration. The clinical data suggest that 
the mwhanism of impaired ischemia is through competitive 
inhibition of adenosine. The delay in the onset of ischemia 
during exercise was not associated with adverse etfects or 
increased chronotropic demand, as shown by oxygen up- 
Table 2. Et&t of Theophyllinr on Thallium-201 lmaaing at Peak 
Exercise in I2 Patients 
FIgwe 1. E&tr of intravenws 11 enphythne cn 
the onset of electrocardio~phic changer in I2 
patients. Significant difference between theophyl- 
line tT) and both placebo (P) and baseline (8): *p < 
0.05; **p < 0.01. Abbreviations and units as in 
Figure I. 
take, symptoms, ECG criteria and thallium-201 imaging at 
the completion of exercise but was associated with a higher 
ischemic threshold. 
Comparison wfth reemt pubtished eqarts. This study con- 
firms and extends the findings of recent reports (14~17) that 
theophylline delays the onset of exercise+duced myocar- 
dial ischemia. Crea et al. (14) reported increased time to the 
onset of both angina and ECG changes in a groap of patients 
using a single-blii protocol with acute administration of 
intravenous theophylline and in 20 patients given an oral 
dosage (14). In a similar study by Crea et al. (17). exercise 
duradou was prolonged. The present study also demonstrated 
adelay in the onset ofisehemia while illustratingthat iscltemia 
was not exacerbated at the completion of the hqer exercise 
period, as cnntimmd by ECG changes, amgina or oxygen 
uptake. In addition, the thallium-201 defect size, previously 
shown to be dependent on work load. was unaltered by the 
theophylline infusion (33). These data provide s~evidenee 
that imhemia was not negatively affected by theophytfine. 
Lwheak Uuwhdd. An imuortant findina of this sNdy 
was the higher ischemie threshold alter administration df 
theophylline. If the mechanism of adenosine action is a 
coronary steal phenomenon, inhibition of this mrddistribw 
tion of blood Row by lheophylline should allow a propwtion- 
ally greater Row to stenotic vessels at a given oxygen 
demand. Thus, a work load that was previously demon- 
strated to urovoke ischemia should nw be isehemia free, as 
we have shown in this study. Such a phenomenon was 
recently suggested by Cannon (IO) and is demonstrated in 
the emrent findings by the higher rate-pressure product and 
oxygen uptake at the onset of either angina or ECG changes 
with theophy!line. 
Clhtkal impikatbnm. The effects of theophylline on the 
ischemic threshold have important clinical implications. 
Recent evidence (2-8) has demonstrated considerable vari- 
ability in the occurrence of ischemia not only during daily 
activities but also under differina labormow conditions. A 
consistent finding of these stukes has deen a lowered 
ischemic threshold with lesser activities such as walking 
than with more viaurous exercise (3.7). Furthermore. such 
ischemia at lower-work levels is often silent and therefore 
unrecognized. New information (34) also suggests that stau- 
dard medical therapies may be ineffective in treating such 
ischemia. Thus. any medication, such as Lheophylline. that 
raises the ischemic threshold may pronde mow benefit to 
patients during daily activities than is orovided by B drug that 
&ply delaysthe &ret of ischemia.. 
The present trial was performed using: one intravenous 
dosage of theaphylline (8 mgniter) compaxd with placebo. 
The dosage chosen was subtheiapeutic for the treatment of 
reactive airways disease but was well within the range that 
would be expected to inhibit adenwine and reverse the 
ischemic effects of intravenous diovridamole for radionu- 
elide imaging (14,35,36). Additionaistudies are needed to 
evaluate whether differine doioses of theoohvlline will also 
have beneficial ctiects on&hernia or wheih& chronotropic 
and :narrhy~hmic effects are limiting. 
Caodusioos. Moderate concentrations of theophylline 
favorably delay the onset of exercise-induced myocardial 
ischemia at a higher ischemic threshold without negatively 
atkting ischemia at peak exercise. The impact on the 
ischemie threshold suggests that the mechanism of the 
anti-ischemic etTects of theophylline may be competitive 
inhibition of adenosine. 
